Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model. Axelsson Raja A, Wakimoto H, DeLaughter DM, Reichart D, et al. Proc Natl Acad Sci U S A 2022;119:e2204174119.

Read + Share

Amedeo Smart

Independent Medical Education

Axelsson Raja A, Wakimoto H, DeLaughter DM, Reichart D, et al. Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model. Proc Natl Acad Sci U S A 2022;119:e2204174119.
PMID: 35787042